INTRODUCTION {#SEC1}
============

Animals have diverse cell types that perform specialized functions while retaining the ability to perform common functions. Such common functions could rely on the same molecular machinery in all cells or on different machinery in different cells. As a result, an apparently uniform organismal response could obscure differences in the mechanisms used by different cells. A common response to viral infection is the silencing of viral genes facilitated by the recognition of viral double-stranded RNA (dsRNA) (reviewed in ([@B1])). The experimental addition of dsRNA triggers similar mechanisms that can silence any matching sequence ([@B2]). This process of RNA interference (RNAi) is a powerful approach for gene silencing applications in a variety of organisms (reviewed in ([@B3])). In the nematode *Caenorhabditis elegans*, exposure to different sources of dsRNA can silence matching genes in many somatic cell types and in the germline ([@B4]). Studies in *C. elegans* have therefore been informative in piecing together the organismal response to RNAi in an animal. While similar silencing responses occur in diverse cell types, it is unclear whether dsRNA from every source engages the same molecular machinery in each cell.

Export of RNA from cells can result in diverse populations of RNA in the extracellular space (reviewed in ([@B7])). In *C. elegans*, systematic expression of dsRNA in multiple tissues suggests that extracellular dsRNA from neurons reliably causes silencing in distant cells ([@B8]). The export of dsRNA could be the result of non-specific processes such as cellular damage or could require secretion mechanisms and specific processing of dsRNA by enzymes that splice ([@B9],[@B10]), edit (reviewed in ([@B11])), or modify ([@B12]) RNA. Collectively, these processes could potentially produce many forms of extracellular dsRNA.

Entry of extracellular dsRNA into the cytosol and subsequent silencing relies on the conserved dsRNA importer SID-1 ([@B13]). SID-1-dependent silencing is observed in many tissues even when dsRNA is expressed within a single tissue, suggesting that form(s) of dsRNA move between cells. In particular, dsRNA expressed in neurons can silence a target gene in somatic tissues such as the intestine, muscle, and hypodermis ([@B8],[@B17],[@B18]) and in the germline ([@B19]). Silencing in these diverse target cells requires the dsRNA-binding protein RDE-4 ([@B20],[@B21]) and the endonuclease DCR-1, which together process dsRNA into small-interfering RNAs (siRNAs) ([@B22],[@B23]), and the Argonaute RDE-1, which binds siRNAs ([@B24]). Upon recognition of a matching mRNA by RDE-1-bound siRNAs, RNA-dependent RNA Polymerases (RdRPs) are recruited, resulting in the production of numerous secondary siRNAs ([@B25],[@B26]). Testing multiple target genes suggests that two different RdRPs are used for silencing: RRF-1 for genes expressed in somatic cells ([@B25]) and EGO-1 for genes expressed in the germline ([@B28],[@B29]). Secondary siRNAs can bind the Argonaute NRDE-3 in somatic cells ([@B30]) or the Argonaute HRDE-1 in the germline ([@B31]) and subsequently accumulate within the nuclei of cells that express the target gene. Through these events, extracellular dsRNA can reduce the levels of mRNA and/or pre-mRNA of a target gene.

While silencing by all extracellular dsRNA requires SID-1, DCR-1, and RDE-1, the requirement for other components can vary. For example, some genes expressed in somatic cells can be silenced by ingested dsRNA in the absence of RRF-1 ([@B34]). While many genes do not require NRDE-3 for silencing, the *bli-1* gene requires NRDE-3 for silencing by ingested dsRNA or neuronal dsRNA ([@B18]). Finally, a strict requirement for NRDE-3 but not for RRF-1 is seen for the silencing of repetitive DNA that occurs in an enhanced RNAi background upon growth at lower temperatures ([@B35]). These observations suggest that a mix of mechanisms could underlie RNAi in *C. elegans*. Experiments that control one variable at a time are needed to elucidate features that dictate the choice of mechanism used for silencing.

Here we reveal that silencing by neuronal dsRNA can differ from silencing by other sources of dsRNA in its requirement for EGO-1 in the absence of RRF-1. We provide a single-cell resolution view of silencing by neuronal dsRNA and find that each animal has a different set of intestinal cells that can rely on EGO-1 for gene silencing.

MATERIALS AND METHODS {#SEC2}
=====================

Strains and oligonucleotides used {#SEC2-1}
---------------------------------

All strains (listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}) were cultured on Nematode Growth Medium (NGM) plates seeded with 100 μl of OP50 at 20°C and mutant combinations were generated using standard methods ([@B36]). Reference alleles indicated as *gene(-)* are as follows: *eri-1(mg366), rrf-1(ok589), rde-1(ne219), rde-11(hj37), sid-1(qt9)*, and *mut-16(pk710)*. Sequences of oligonucleotides used to genotype different mutant combinations are in [Supplementary Table S2](#sup1){ref-type="supplementary-material"} (*eri-1*: P01-P02, *rde-1*: P03-P04, *rde-11*: P05-P06, *sid-1*: P07-P08, *rrf-1*: P09-P11, *mut-2/rde-3*: P12-P13 and *mut-16*: P14-P15).

Transgenesis {#SEC2-2}
------------

*Caenorhabditis elegans* was transformed with plasmids and/or PCR products using microinjection ([@B37]) to generate extrachromosomal or integrated arrays. pHC337 was used to express an inverted repeat of *gfp* in neurons ([@B8]), which is expected to generate a hairpin RNA (*gfp-*dsRNA). Generation of the array that expresses *unc-22*-dsRNA in neurons (*qtEx136)* was described earlier ([@B17]). To rescue silencing defects in *rde-1(jam1)* and *rrf-1(jam3)* animals ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}), genomic DNA from wild-type animals (N2 gDNA) was used as a template to generate fused promoter/gene products through overlap extension PCR using Expand Long Template polymerase (Roche) and PCR products were purified using QIAquick PCR Purification Kit (Qiagen). The plasmid pHC448 for *DsRed2* expression in the pharynx or a PCR product, *Prgef-1::DsRed2::unc-54 3′ UTR*, for *DsRed2* expression in neurons was used as a co-injection marker ([@B17]). Additional details are provided in [Supplementary Materials and](#sup1){ref-type="supplementary-material"} Methods.

Genome editing {#SEC2-3}
--------------

Synthetic CRISPR RNA (crRNA) and trans-activating crRNA (tracrRNA) (IDT) or single guide RNAs (sgRNA) transcribed in vitro were combined with Cas9 protein (PNA Bio Inc. or IDT) to generate complexes used for genome editing. To transcribe guide RNAs, the scaffold DNA sequence was amplified from pDD162 (*Peft-3::Cas9* + *dpy-10* sgRNA - Addgene plasmid \# 47549, a gift from Bob Goldstein) ([@B38]) using a common reverse primer (P16) and target-specific forward primers (see [Supplementary Table S2](#sup1){ref-type="supplementary-material"}), purified (PCR Purification Kit, Qiagen), and used for in vitro transcription (SP6 RNA polymerase, NEB). Deletions were made using two guide RNAs and a single-stranded DNA oligonucleotide repair template with a co-conversion strategy ([@B39]). Insertions of *gfp* were performed using a single guide RNA and a double-stranded repair template amplified using PCR ([@B40]). *Punc-22::unc-22::gfp* resulted in GFP fluorescence within the pharynx as reported earlier ([@B41]). Additional details are provided in [Supplementary Materials and](#sup1){ref-type="supplementary-material"} Methods.

Feeding RNAi {#SEC2-4}
------------

One generation of feeding RNAi was performed as described earlier ([@B15]) and the numbers of brightly fluorescent intestinal nuclei in animals subject to RNAi were counted for Figure [1D](#F1){ref-type="fig"}.

![Silencing by different sources of double-stranded RNA show synergy and can have different requirements for the RNA-dependent RNA polymerase RRF-1. (**A**) Silencing upon loss of *eri-1* and by neuronal dsRNA shows synergy. Representative L4-staged animals that express GFP (black) in all tissues (*sur-5::gfp*) in *eri-1(+)* (i.e., wild-type) or *eri-1(-)* backgrounds and animals that in addition express dsRNA against *gfp* in neurons (*Prgef-1::gfp*-dsRNA) in either background are shown. Brackets indicate silenced intestinal nuclei. Average numbers of GFP positive intestinal nuclei are indicated with 95% confidence intervals (n = 20 animals). Scale bar = 50 μm. (**B**) Schematic of *gfp* silencing in intestinal cells. Silencing by neuronal dsRNA (blue) and by dsRNA made from a multicopy *sur-5::gfp* transgene (orange) are both inhibited by the endonuclease ERI-1. (**C**) Combined silencing by the two sources of dsRNA is strictly dependent on *sid-1, rde-1*, and *rde-11*, but partially dependent on *rrf-1*. Silencing of *sur-5::gfp* was measured by counting the number of GFP-positive intestinal nuclei in animals expressing no dsRNA in an *eri-1(+)* or *eri-1(-)* background, in animals expressing *Prgef-1::gfp-*dsRNA in an *eri-1(+)* or *eri-1(-)* background, and in animals expressing *Prgef-1::gfp-*dsRNA in an *eri-1(-)* background with additional mutations in *sid-1, rde-1, rde-11 or rrf-1*. Known null alleles are represented as *gene(-)* (see Materials and Methods for allele names) and alleles isolated in the screen are represented as *gene(jam\#)*. Red bars indicate medians, *n* ≥ 20 L4-staged animals and asterisks indicate *P*-value \<0.05 (Student\'s t-test). (**D**) Unlike silencing by target-derived dsRNA or ingested dsRNA, silencing by neuronal dsRNA is partially independent of RRF-1 and strongly dependent on RDE-11. Silencing was separately measured for the three sources of dsRNA: target-derived dsRNA upon loss of *eri-1* in *eri-1(-), eri-1(-); rde-11(-)* or *eri-1(-); rrf-1(-)* animals (orange), neuronal dsRNA upon expression of *Prgef-1::gfp*-dsRNA in *eri-1(+), eri-1(+); rde-11(-)* or *eri-1(+); rrf-1(-)* animals (blue), or ingested dsRNA from bacteria expressing *gfp*-dsRNA in *eri-1(+), eri-1(+); rde-11(-)*, or *eri-1(+) rrf-1(-)* animals (black). Red bars, n, and asterisks are as in C, and ns = not significant.](gkz748fig1){#F1}

Genetic screen and whole genome sequencing {#SEC2-5}
------------------------------------------

AMJ1 animals were mutagenized with 25 mM N-ethyl N-nitrosourea (ENU, Toronto Research Chemicals) and ∼600,000 of their F2 progeny were screened for recovery of GFP expression in intestinal cells (performed by A.M.J. in Craig Hunter\'s lab, Harvard University). For 23 mutants that showed different degrees of fluorescence, we prepared genomic DNA from ∼1--2 ml of worms (200--800 ng/μl of DNA per mutant, NanoVue Plus (GE)). Libraries for Illumina sequencing were prepared at the IBBR sequencing core as per manufacturer\'s instructions and sequenced using a HiSeq1000 (Illumina).

Bioinformatic analysis {#SEC2-6}
----------------------

All bioinformatic analyses were done using the web-based Galaxy tool collection (<https://usegalaxy.org>) ([@B42]). For each of the 23 mutant strains, we obtained ∼40 million 101 base fastq reads on average ([Supplementary Table S3](#sup1){ref-type="supplementary-material"}). One 5*′*-end base and three 3*′*-end bases were of lower quality and were trimmed from all reads before alignment to ce6/WS190 using Bowtie (∼36 million mapped reads per mutant on average). Sequence variants were filtered to call mutations (Phred33 ≥20, ≥2 aligned reads, and same variant call in ≥66% of reads). We intended to rescue any *sid-1* mutations that might arise in the screen to avoid isolating many alleles of *sid-1* (∼100 alleles of *sid-1* were isolated in the original *sid* screen ([@B13])). However, our sequencing data revealed that we had instead inadvertently introduced a non-functional copy with 12 missense mutations as part of the *qtIs50* transgene ([Supplementary Figure S1C](#sup1){ref-type="supplementary-material"}). Therefore, the threshold for calling a mutation was reduced from 66% to 15% for *sid-1* sequences. For all mutants, non-synonymous changes, changes in splice junctions, and deletions (characterized by lower than average coverage) were analyzed further. Identical changes detected in two or more mutants were eliminated as potential background mutations that were likely present before mutagenesis. Pairwise comparisons were carried out between all mutants to identify cases of different mutations in the same gene (i.e. in silico complementation ([@B45])). Because this process entails 253 pairwise comparisons, we expect that one or two such shared genes will be identified for some mutant pairs at random. For example, for mutant pairs with 30 mutated genes each, the *P*-value for one shared gene (0.044) and that for two shared genes (0.0009) are both larger than the Bonferroni corrected *P*-value of 0.0002 for 253 comparisons at α = 0.05 ([@B46]).

Single-molecule RNA fluorescence in situ hybridization (smFISH) {#SEC2-7}
---------------------------------------------------------------

smFISH was performed as described earlier ([@B47],[@B48]). Briefly, custom Stellaris probes recognizing exons of *gfp* (probes spanning exon-exon junctions were not included) labeled with Quasar 670 dye (Biosearch Technologies) were added to fixed L4-staged animals. RNA hybridization was performed with 0.025 μM of probe mix for 48 h at 37°C in 100 μl of hybridization buffer (10% dextran sulphate (w/v), 2× saline-sodium citrate (SSC), 10% formamide (v/v)). Following a wash in wash buffer (2× SSC, 10% formamide, 0.1% Tween-20 (v/v)) samples were stained with DAPI (4′,6-diamidino-2-phenylindole) for 2 h at room temperature and washed 5 more times. Before imaging, samples were stored in GLOX (2× SSC, 0.4% glucose (w/v), 0.01M Tris, pH 8.0) buffer at 4°C for fewer than 3 hours. Samples were mounted in 10 μl of GLOX buffer and enzymes (glucose oxidase, catalase, and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox)) and coverslips were sealed with a melted mixture of vaseline, lanolin and paraffin.

Western blotting {#SEC2-8}
----------------

Mixed stage animals were washed off three to five 100 mm plates and used for western blot analysis. Samples were sonicated four times (40% amplitude with 45 s pauses between 15 s pulses) using a probe sonicator with a microtip (Branson Sonifier). Proteins were separated on a 14% SDS-PAGE and then blotted onto nitrocellulose paper (TransBlot™ Turbo Midi transfer pack). The blot was probed for GFP first, stripped (incubated in 0.2% sodium dodecyl sulfate, 0.1 M Tris, pH 8.0 and 1.4% β-mercaptoethanol for 1 h at 65°C), and then probed for Tubulin. The following primary antibodies were used: mouse anti-α-Tubulin (Sigma: T5168; 1:4000 dilution) and mouse anti-GFP (Thermo Fisher Scientific: MA5-15256; 1:2000 dilution). The following corresponding secondary antibodies were used: Rabbit anti-mouse IgG1 HRP (Sigma: SAB3701171, 1:250 dilution) and goat anti-Mouse IgG(H+L) HRP (Thermo Fisher Scientific: 32430, 1:750 dilution). Blots were developed using chemiluminescence detection reagents (Thermo Fisher Scientific: SuperSignal™ West Pico PLUS) and imaged using a ChemiDoc (Bio-Rad). The western blots in [Supplementary Figure S3D](#sup1){ref-type="supplementary-material"} are representative of three technical replicates. Signal of the band of interest was quantified using FIJI (NIH, ([@B49])) and is reported as median of ratios with respect to α-tubulin.

Microscopy {#SEC2-9}
----------

For Figures [2A](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"} and [Supplementary Figures S3B, S5, S6B, S6D and S7](#sup1){ref-type="supplementary-material"}, animals were immobilized in 5 μl of 3 mM levamisole (Sigma-Aldrich; catalog no. 196142), mounted on slides, and imaged using an AZ100 microscope (Nikon) at a fixed magnification under non-saturating conditions of the tissue being quantified for silencing. A C-HGFI Intensilight Hg Illuminator was used to excite GFP (filter cube: 450--490 nm excitation, 495 nm dichroic, 500--550 nm emission), which also resulted in some bleed through from the DsRed fluorescence (e.g. Figure [3A](#F3){ref-type="fig"}). For Figure [4A](#F4){ref-type="fig"}--[D](#F4){ref-type="fig"} and [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}, L4-staged worms were mounted onto a slide with a 3.5% agarose pad after incubating the worm for 10 minutes in 7μl of 1mM freshly made levamisole. Extended exposure to levamisole was necessary for reliable immobilization of the worm for the ∼100 min of imaging that was required to obtain 512 × 512 images of entire L4-staged *sur-5::gfp* worms using a 63× lens in a Leica SP5X confocal microscope (average of 3 measurements per line, 319 slices per section, 5 sections, and 0.125 μm between slices). A 488 nm laser was used to excite GFP (emission: 498--550 nm, NA = 1.4). For Figure [4E](#F4){ref-type="fig"} and [F](#F4){ref-type="fig"}, DAPI, GFP and Quasar 670 fluorescence in intestinal cells anterior to the germline and posterior to the pharynx was acquired as 1024 × 1024 images (six slices, 0.5 μm between slices) using a 63× lens and 2× digital zoom in a Leica SP5X confocal microscope. GFP was excited as described above, a 405 diode laser was used to excite DAPI (emission: 422--481 nm, 9% power) and a 633nm laser was used to excite Quasar 670 (emission: 650--715 nm, 50% power).

![Silencing that can bypass a requirement for RRF-1 requires EGO-1 and MUT-16. (**A**) Silencing by neuronal dsRNA in the absence of RRF-1 is detectable for single-copy target sequences. Representative L4-staged animals that express GFP from a single-copy transgene in all tissues (*Peft-3::gfp, top*) and animals that in addition express *Prgef-1::gfp-*dsRNA in *rrf-1(+)* or *rrf-1(-)* backgrounds (*middle* or *bottom*, respectively) are shown. Insets are representative of the region quantified in multiple animals in B. Scale bar = 50 μm. Also see [Supplementary Figure S3](#sup1){ref-type="supplementary-material"} for additional targets. (**B**) Silencing of *Peft-3::gfp* in the absence of *rrf-1* requires *rde-11, mut-16*, and *mut-2/rde-3*. GFP fluorescence was quantified (using arbitrary units (a.u.) in regions illustrated in (A)) in control animals that do not express *Prgef-1::gfp-*dsRNA (grey) and in animals that express *Prgef-1::gfp-*dsRNA (blue) in wild-type (+/+), *rrf-1(-), rde-11(-), mut-16(-)* or *mut-2(-)* backgrounds. (**C**). The RdRP EGO-1 is required for silencing *Peft-3::gfp* in the absence of RRF-1, while the putative RdRP RRF-2 and the known RdRP RRF-3, do not compensate for the absence of RRF-1. As in (B), GFP fluorescence was quantified in control animals that do not express *Prgef-1::gfp-*dsRNA (grey) and in animals that express *Prgef-1::gfp-*dsRNA (blue) in wild-type (+/+), *rrf-1(-), rrf-1(-) mut-16(-), rrf-1(-) rrf-2(-), rrf-1(-); rrf-3(-), or rrf-1(-) ego-1(-)* backgrounds. Red bars indicate medians, asterisks indicate *P*-value \< 0.05 (Student\'s t-test) and n \> 25 L4-staged animals except in *rrf-1(-) ego-1(-)* where *n* = 11. See [Supplementary Figure S4](#sup1){ref-type="supplementary-material"} for details of *rrf-2, rrf-3* and *ego-1* alleles.](gkz748fig2){#F2}

![Changing the gene context of a target sequence can change the RRF-1 requirement for silencing that sequence. (**A**) *Top left*, Strategy for combining target sequences from experiments that showed different RRF-1 requirements to test silencing of a single chimeric target by neuronal dsRNA. The *gfp* sequence (blue) was inserted into the *unc-22* gene (black) at either the 5*′* or 3*′* ends to generate single chimeric target genes that can be silenced by either *gfp*-dsRNA or *unc-22*-dsRNA. See [Supplementary Figure S4](#sup1){ref-type="supplementary-material"} for details of *gfp* insertions. *Top right*, Representative L4-staged animals that express GFP from *Punc-22::gfp::unc-22* and animals that in addition express *Prgef-1::gfp-*dsRNA (blue, *middle*) or *Prgef-1::unc-22*-dsRNA (black, *bottom*) in *rrf-1(+)* (*left*) or *rrf-1(-)* (*right*) backgrounds are shown. Fluorescence in the pharynx is observed in cases where *Prgef-1::gfp*-dsRNA is present (*middle*) because of expression from the co-injection marker *Pmyo-2::DsRed2* (filled circle) detected through the filters for GFP (see Materials and Methods). Animals with *Prgef-1::unc-22*-dsRNA have *Prgef-1::DsRed2* as a co-injection marker, which results in similarly detectable bleedthrough signal in the head region (*bottom*). Brackets indicate regions of silencing. Scale bar = 50 μm. (**B**) *Left*, GFP fluorescence from the chimeric gene (*Punc-22::gfp::unc-22*) was quantified (posterior to the pharynx) in control animals (*rrf-1(+)*) that do not express dsRNA (grey) and in animals that express either *Prgef-1::gfp*-dsRNA (blue) or *Prgef-1::unc-22*-dsRNA (black) in *rrf-1(+)* or *rrf-1(-)* backgrounds. Red bars, a.u., and *n* are as in Figure 2B, asterisks indicate *P*-value \<0.05 (Student\'s t-test), and ns = not significant. *Right*, Percentage of animals that showed twitching (%Unc) expected upon silencing *Punc-22::gfp::unc-22* was scored for all strains shown in (A). Error bars indicate 95% confidence intervals, asterisks indicate *P*-value \< 0.05 (Student\'s *t*-test), ns = not significant, and *n* = 50 L4-staged animals. Also see [Supplementary Figure S6](#sup1){ref-type="supplementary-material"} for silencing of another chimeric target, *Punc-22::unc-22::gfp*.](gkz748fig3){#F3}

![Identities of cells that require RRF-1 for silencing by neuronal dsRNA vary from animal to animal. (**A**) GFP expression from the *sur-5::gfp* chimeric gene enables simultaneous visualization of most somatic nuclei in *C. elegans*. A depth coded (one color for ∼53 frames) projection of 5 Z-stacks that were stitched together from a single L4-staged animal is shown (also see Materials and Methods). Scale bar = 100 μm. (**B-D**) Expression of *gfp*-dsRNA in neurons causes silencing throughout the animal that is entirely dependent on SID-1 and partially dependent on RRF-1. Representative images of L4-staged *sur-5::gfp* animals that express *Prgef-1::gfp*-dsRNA (B) and additionally lack *sid-1* (C) or *rrf-1* (D) are shown. Maximum intensity projections of sections were stitched together to generate whole-worm images. Presence of *gfp-*dsRNA causes worms to twist because of the *rol-6* co-injection marker. Cells that require RRF-1 for silencing (e.g. the excretory canal cell indicated by red arrows and some intestinal cells in red dashed lines) and cells that can silence in the absence of RRF-1 (e.g. some intestinal cells shown in blue dashed lines) are highlighted in *Prgef-1::gfp-*dsRNA*; rrf-1(-)* and in *Prgef-1::gfp*-dsRNA; *sid-1(-)* animals. Scale bar = 100μm. (**E, F**) Silencing in *rrf-1(-*) animals by neuronal dsRNA is associated with a decrease in *sur-5::gfp* mRNA levels. Single molecule FISH was used to detect *sur-5::gfp* mRNA in L4-staged wild-type animals (E, *left*) or in *sur-5::gfp* animals that express *Prgef-1::gfp-*dsRNA (E, *middle*) and that in addition lack *sid-1* (E, *right*) or *rrf-1* (F). RNA from *Prgef-1::gfp-*dsRNA is prominently detected by *gfp* probes in neuronal nuclei (red arrows and bracket). A representative pair of intestinal nuclei is shown for each animal as an overlay of DNA (DAPI in blue), mRNA (*gfp* in green) and protein (GFP in magenta). Cytoplasmic mRNA foci were counted (see Materials and Methods) between two nuclei in wild-type or in *sid-1(-)* backgrounds (E), and between two nuclei where GFP is silenced (off, blue) and where GFP is expressed (on, red) in *rrf-1(-)* animals. Errors indicate 95% confidence intervals, *n* = 3 in E and *n* = 4 in F. Top scale bar = 10 μm and bottom scale bar = 5 μm. (**G**) No intestinal cell requires RRF-1 for silencing in all animals. The E blastomere divides to generate 20 intestinal cells (EaLAAD to EpRPPP). Of the 20 cells, 10 undergo nuclear division without cell division (two grey circles per cell), 4 sometimes undergo similar nuclear division (one grey circle and one open circle per cell), and 6 do not undergo any division (one grey circle per cell). In each of 10 *sur-5::gfp; rrf-1(-); Prgef-1::gfp*-dsRNA L4-staged animals, GFP-positive nuclei (use only RRF-1, gray) and GFP-negative nuclei (use EGO-1 or RRF-1, white) were scored. Every binucleate cell had both nuclei with the same requirement. White boxes with a slash indicate absence of second nucleus because of lack of nuclear division ([@B52]). See [Supplementary Figure S7](#sup1){ref-type="supplementary-material"} for images of additional animals.](gkz748fig4){#F4}

Image processing {#SEC2-10}
----------------

All images being compared in a figure were adjusted identically using Adobe Photoshop and/or FIJI (NIH). Images taken on Nikon AZ100 were inverted (GFP = black), look-up tables were changed using Photoshop (190 = white and 255 = black for *gtbp-1::gfp, eft-3::gfp, gfp::unc-22* and *unc-22::gfp*; 212 = white and 255 = black for *sur-5::gfp*), and cropped for display. When imaging using the SP5X confocal microscope (Figure [4A](#F4){ref-type="fig"}-[D](#F4){ref-type="fig"} and [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}), our immobilization conditions resulted in the worm lying on the coverslip such that the middle of the worm (vulva region) was tightly sandwiched between the coverslip and the agarose pad but the rest of the worm (head and tail in particular) was free to assume different positions. To partially account for this variability and the observed loss in sensitivity with depth of imaging, stacks close to the coverslip that lacked any signal were removed (0--30 stacks, median 7 stacks) and an equivalent number of empty stacks were added beyond the worm for a consistent total of 319 stacks in all cases. For Figure [4A](#F4){ref-type="fig"}--[D](#F4){ref-type="fig"}, Z-projections of the five stacks for each worm were stitched together using a combination of a pairwise stitching plugin ([@B50]) and manual alignment (Adobe Illustrator). For Figure [4A](#F4){ref-type="fig"}, each Z-stack was depth-coded using the 'temporal-color code' function in FIJI (6 colors with 53 stacks/color). For [Supplementary Figure S8A](#sup1){ref-type="supplementary-material"}, Z projections of maximum intensity were created using all 319 stacks (head and tail) or a subset of stacks (seam, uterus and vulva). For Figure [4E](#F4){ref-type="fig"} and [F](#F4){ref-type="fig"}, [Z](#F4){ref-type="fig"} projections of maximum intensity were created using five slices, inverted (GFP = black), cropped for display (full anterior region or zoomed-in region between two nuclei) and look-up tables were changed using Photoshop (160 = white and 255 = black). Composites of GFP, DAPI and Quasar 670 were created on FIJI (NIH) and look-up tables were changed to magenta, blue, or green.

Quantification of silencing {#SEC2-11}
---------------------------

Silencing in response to *unc-22-*dsRNA was scored by calculating the percentage of L4-staged animals that twitched within 3 min in 3 mM levamisole. The silencing of GFP expressed from *nrIs20* (*sur-5::gfp)* was determined by counting the number of intestinal nuclei that showed bright GFP fluorescence in L4-staged animals at a fixed magnification and zoom using a MVX10 stereomicroscope (Olympus). Average number of intestinal nuclei were determined by counting HC195 and was relatively constant in most genetic backgrounds with the exception of strains that lacked *rrf-1* (e.g. 32.8 ± 0.6 nuclei in *rrf-1(-); nrIs20* animals and 32.3 ± 0.8 nuclei in *rrf-1(-); eri-1(-) nrIs20* animals, compared to 29.9 ± 1.2 nuclei in *nrIs20* animals, errors indicate 95% CI). For images acquired using Nikon AZ100, silencing was quantified using FIJI (NIH) by measuring the fluorescence posterior to the pharynx in a region of interest (ROI) that included either a fixed area anterior to the germline (Figure [2](#F2){ref-type="fig"} and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}) or body-wall muscles all along the worm (Figure [3](#F3){ref-type="fig"} and [Supplementary Figure S6](#sup1){ref-type="supplementary-material"}), using the formula ROI fluorescence (arbitrary units) = intensity of ROI -- (area of ROI × mean intensity of background). For images acquired using the SP5X confocal microscope, a combination of thresholding using the 3D object counter plugin ([@B51]) on FIJI (NIH) and manual verification was used to count various nuclei. To score nuclei as 'on' or 'off', different thresholds were used for intestinal nuclei located at different depths (70 for stacks 1--160; 20 for stacks 161--319) and a constant threshold was used for all other nuclei (20 for all stacks). For Figure [4E](#F4){ref-type="fig"} and [F](#F4){ref-type="fig"}, the number of mRNA foci was counted using the 3D object counter on FIJI (NIH). A threshold of 50 was selected, objects \<0.015 μm^3^ were eliminated as background, and objects \>0.2 μm^3^ were eliminated as miscounts due to merging of multiple objects. For Figure [4G](#F4){ref-type="fig"}, the identity of each intestinal nucleus was inferred using its expected location and using the position of the vulva, anus, and the twisting rows of hypodermal cells (twist induced by the *rol-6* co-injection marker for *gfp-*dsRNA \[*qtIs49*\]) as guideposts ([@B52]).

Statistics {#SEC2-12}
----------

Significance of differences in silencing (*P*-value \< 0.05, unless otherwise stated) were calculated using Student\'s t-test (two tailed) or a two-way analysis of variation (ANOVA) with replication. Error bars in Figure [3B](#F3){ref-type="fig"}, *Right* and [Supplementary Figure S6A and S6C](#sup1){ref-type="supplementary-material"}, *Right* indicate 95% confidence intervals for single proportions calculated using Wilson\'s estimates with a continuity correction (Method 4 in ([@B58])) and significance of differences between strains was determined using pooled Wilson\'s estimates.

RESULTS {#SEC3}
=======

Silencing by neuronal dsRNA can be distinct from silencing by ingested or target-derived dsRNA {#SEC3-1}
----------------------------------------------------------------------------------------------

Double-stranded RNA can be introduced into *C. elegans* cells through the transcription of complementary sequences within the target cell, in a distant cell, or in ingested bacteria. While all these sources of dsRNA trigger RDE-1-dependent gene silencing ([@B59]), each source could produce different pools of dsRNA and/or dsRNA-derivatives that are trafficked differently to the cytosol of the target cell where silencing occurs. Here we present evidence that different sources of dsRNA can differ in their requirement for RRF-1 to silence the same target gene.

To examine silencing of a single target by different sources of dsRNA, we used a nuclear-localized GFP that is expressed in all somatic cells (*sur-5::gfp*) and is particularly prominent in the large intestinal nuclei (Figure [1A](#F1){ref-type="fig"}, *Top left*, ∼30 GFP+ nuclei). This target is a multicopy transgene that generates trace amounts of dsRNA that can cause self-silencing in enhanced RNAi backgrounds (e.g. *adr-1(-); adr-2(-)* in ([@B60]) and *eri-1(-)* or *rrf-3(-)* in ([@B35])). Silencing by this target-derived dsRNA was modest (Figure [1A](#F1){ref-type="fig"}, ∼24 GFP+ nuclei in *eri-1(-), P*-value *\<* 10^−3^ when compared to ∼30 GFP+ nuclei in *eri-1(+)*), consistent with earlier reports ([@B8],[@B35]). Similarly, silencing by *gfp-*dsRNA expressed in neurons (*Prgef-1::gfp*-dsRNA) was also modest (Figure [1A](#F1){ref-type="fig"}, ∼24 GFP+ nuclei, *P*-value *\<* 10^−4^ when compared to *eri-1(+)*), consistent with an earlier report ([@B17]). However, when both target-derived and neuronal dsRNA were present together (i.e. in *eri-1(-); Prgef-1::gfp*-dsRNA animals), we observed a synergistic effect resulting in greatly enhanced silencing (Figure [1A](#F1){ref-type="fig"}, ∼3 GFP+ nuclei, two-way ANOVA *P*-value \< 10^−20^ for interaction). This enhancement, taken together with the previous observation that ERI-1 inhibits silencing by neuronal *unc-22*-dsRNA ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"} in ([@B17])), suggests that ERI-1 inhibits silencing by *gfp*-dsRNA generated from the target and *gfp*-dsRNA imported from neurons (Figure [1B](#F1){ref-type="fig"}). Upon performing a genetic screen using these robustly silenced animals, we isolated alleles of four genes with known roles in RNAi - *rde-1, rde-11, sid-1* and *rrf-1* (Figure [1C](#F1){ref-type="fig"}, [Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Surprisingly, unlike in null mutants of *rde-1, rde-11*, or *sid-1*, significant silencing (*P*-value \< 10^−7^) was detectable in null mutants of *rrf-1* (Figure [1C](#F1){ref-type="fig"}) - a property shared by all three alleles of *rrf-1* isolated in the screen (Figure [1C](#F1){ref-type="fig"}). Tissue-specific rescue experiments suggest that both *rde-1* and *rrf-1* function in the intestine (target cells) and not in neurons (source cells) to enable the observed silencing of intestinal cells ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Thus, when both target-derived dsRNA and neuronal dsRNA were used together to silence the same gene, RDE-1-dependent but RRF-1-independent silencing was detectable in some intestinal cells.

This bypass of RRF-1 could be a feature of silencing by target-derived dsRNA, neuronal dsRNA, or a general feature of silencing by all sources of dsRNA. To determine RRF-1 requirements for silencing by different sources of dsRNA, we examined silencing by target-derived dsRNA using an *eri-1(-)* background, silencing by neuronal dsRNA in an *eri-1(+)* background, and silencing by ingested dsRNA in an *eri-1(+)* background. All three sources of dsRNA strictly required RDE-11, a dosage-sensitive RNAi factor ([@B61],[@B62]). In contrast, the requirement for RRF-1 varied depending on the source of dsRNA. The weak silencing by target-derived dsRNA was completely abolished in *rrf-1* null mutants (Figure [1D](#F1){ref-type="fig"} orange). Equally weak silencing by neuronal dsRNA was not significantly altered in *rrf-1* null mutants (Figure [1D](#F1){ref-type="fig"} blue). Yet, robust silencing by ingested dsRNA was strongly dependent on RRF-1 (Figure [1D](#F1){ref-type="fig"} black). These source-dependent differences in extents of silencing could be caused by differences in the routes taken by dsRNA to reach the silencing machinery, the forms of dsRNA and/or the dosages of dsRNA. However, because weak silencing by neuronal dsRNA was partially independent of RRF-1, while strong silencing by ingested dsRNA was primarily dependent on RRF-1, a high dose of dsRNA from neurons cannot be the sole explanation for the observed RRF-1 independence. Therefore, these observations suggest that mechanisms engaged by ingested or target-derived dsRNA can differ from those engaged by neuronal dsRNA.

EGO-1 can compensate for lack of RRF-1 {#SEC3-2}
--------------------------------------

To determine if other targets could show silencing by neuronal dsRNA in the absence of RRF-1, we used the same source of neuronal dsRNA and examined silencing of GFP expression under the control of a different promoter introduced into different genomic loci. Silencing of *gfp* expressed under the control of the *eft-3* promoter (*Peft-3::gfp*) from a single-copy transgene was partially independent of RRF-1 (Figure [2A](#F2){ref-type="fig"}). In the absence of RRF-1, a significant reduction in GFP fluorescence was detectable (Figure [2B](#F2){ref-type="fig"}). A similar extent of silencing in *rrf-1(-)* animals was observed using *Peft-3::gfp* transgenes located on three different chromosomes ([Supplementary Figure S3A](#sup1){ref-type="supplementary-material"}) and for a C-terminal *gfp* fusion of a ubiquitously expressed gene ([Supplementary Figure S3B](#sup1){ref-type="supplementary-material"} and [Supplementary Figure S3C](#sup1){ref-type="supplementary-material"}) generated using Cas9-based genome editing ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). Thus, a measurable amount of silencing by neuronal dsRNA can occur in the absence of RRF-1 when *gfp* is expressed under the control of different promoters and from different chromosomes.

Although it is formally possible that neuronal dsRNA engages novel processing pathways that are not used by other sources of dsRNA, we found that additional components of canonical RNAi were required for silencing (Figure [2B](#F2){ref-type="fig"} and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). RDE-11, thought to facilitate the production of secondary siRNA ([@B61],[@B62]), was required for most silencing (Figure [2B](#F2){ref-type="fig"}). MUT-16, a poly-Q/N protein ([@B63]) and MUT-2/RDE-3, a putative nucleotidyltransferase ([@B64]), that together localize to perinuclear foci thought to be sites of secondary siRNA production ([@B65],[@B66]), were both required for all observed silencing (Figure [2B](#F2){ref-type="fig"}). Consistently, GFP protein levels in *mut-16(-)* animals were greater than that in *rrf-1(-)* animals ([Supplementary Figure S3D](#sup1){ref-type="supplementary-material"}). Removal of MUT-16 in the *rrf-1(-)* background ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}) resulted in weaker silencing of this target (see persistent nuclear fluorescence in [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}) and complete loss of silencing for another target (see below). These results suggest that silencing by neuronal dsRNA in the absence of RRF-1 either occurs through the action of primary siRNAs along with canonical factors such as RDE-11, MUT-16, and MUT-2/RDE-3, or through the production of secondary siRNAs using an alternative RdRP.

The *C. elegans* genome has four genes that encode proteins with RdRP domains, three of which have demonstrated roles in the production of RNA using RNA templates. RRF-3 is thought to act as a processive RdRP in an endogenous pathway ([@B67], [Supplementary Figure S9](#sup1){ref-type="supplementary-material"} in ([@B68])) that competes with experimental RNAi for shared components ([@B69]) and therefore loss of *rrf-3* enhances RNAi ([@B70]). RRF-1 and EGO-1 are thought to act as non-processive RdRPs that make siRNAs in the soma ([@B25],[@B26],[@B69]) and the germline ([@B71]), respectively. Preventing germline proliferation in *rrf-1(-)* animals was found to greatly reduce the levels of secondary siRNAs but not eliminate them ([@B72]), leaving open the possibility that the residual secondary siRNAs may be generated by an alternative RdRP. The fourth putative RdRP, RRF-2, was found to be not required for silencing by ingested dsRNA ([@B27]). To test if the silencing observed in the absence of RRF-1 depends on any of these other RdRPs, we generated mutants lacking RRF-2, RRF-3, or EGO-1 using Cas9-based genome editing ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). In an *rrf-1(-)* background, loss of *rrf-2* did not eliminate silencing and loss of *rrf-3* resulted in enhancement of silencing (Figure [2C](#F2){ref-type="fig"} and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}). Evaluation of the loss of *ego-1* is complicated by the sterility of *ego-1(-)* animals, reflecting the role of EGO-1 in germline development ([@B28],[@B29]). However, *ego-1(-)* progeny of heterozygous animals lacked all silencing in the absence of *rrf-1* despite the potential for parental rescue of *ego-1* (Figure [2C](#F2){ref-type="fig"} and [Supplementary Figure S5](#sup1){ref-type="supplementary-material"}), suggesting that EGO-1 made in progeny compensates for the absence of RRF-1. Hereafter, we shall refer to silencing in the absence of RRF-1 as silencing using EGO-1.

Taken together, these results reveal instances of silencing in somatic cells by a source of neuronal dsRNA through the use of two different RdRPs.

Context of target sequence can dictate RdRP usage {#SEC3-3}
-------------------------------------------------

Expression of dsRNA in neurons does not always cause detectable silencing in the absence of RRF-1, suggesting that EGO-1 is not used in all contexts. For example, neuronal dsRNA targeting *unc-22* (([@B17]), [Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}) or *bli-1* ([Supplementary Figure S6A](#sup1){ref-type="supplementary-material"}) required RRF-1 for all silencing. Nevertheless, targeting *gfp* sequences using neuronal dsRNA resulted in silencing using EGO-1 in animals that lack *rrf-1* (in Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, and [Supplementary Figure S3](#sup1){ref-type="supplementary-material"} using an integrated *gfp*-dsRNA source, and in 6/6 *rrf-1(-); gtbp-1::gfp* animals using an extrachromosomal *gfp*-dsRNA source). These results suggest that silencing in somatic cells using EGO-1 is not a generic property of all neuronal dsRNA and raise two possibilities: (1) sources that do not strictly require RRF-1 (e.g. neuronal *gfp*-dsRNA) differ from sources that require RRF-1 (e.g. neuronal *unc-22*-dsRNA); or (2) target sequences that do not strictly require RRF-1 (e.g. *gfp*) differ from target sequences that require RRF-1 (e.g. *unc-22*).

To examine silencing of a single target sequence by either source of dsRNA, we generated two chimeric genes (*gfp::unc-22* or *unc-22::gfp*) that could both be silenced by either *gfp*-dsRNA or *unc-22*-dsRNA expressed in neurons (Figure [3A](#F3){ref-type="fig"}, *top left*). Both chimeric genes express *unc-22* and *gfp* sequences as a single transcript under the control of endogenous *unc-22* regulatory sequences ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}) and were functional as evidenced by lack of twitching (Figure [3B](#F3){ref-type="fig"}, *right*), which is a sensitive readout of reduction in *unc-22* function ([@B2]). With either source of dsRNA, all measurable silencing required RRF-1 (Figure [3](#F3){ref-type="fig"}, [Supplementary Figures S6B and S6C](#sup1){ref-type="supplementary-material"}). This complete dependence on RRF-1 was more evident when twitching was measured in response to the expression of either *gfp-*dsRNA or *unc-22-*dsRNA in neurons (Figure [3B](#F3){ref-type="fig"}, *right*).

These results suggest that changing the context of a target sequence can change its need for RRF-1 versus the alternative use of EGO-1 for silencing by neuronal dsRNA. Specifically, silencing of the single-copy *gfp* target by neuronal *gfp*-dsRNA could use EGO-1 when *gfp* is present as part of *eft-3::gfp* or *gtbp-1::gfp* but not as part of *unc-22::gfp*. These differences in genomic location, associated regulatory elements, or site of expression could be responsible for the observed differential use of EGO-1.

Somatic cells that can use EGO-1 for silencing vary from animal to animal {#SEC3-4}
-------------------------------------------------------------------------

To examine the use of EGO-1 for silencing in all somatic cells while keeping the genomic location and associated regulatory elements of the target gene constant, we generated a chimeric gene with *gfp* sequence fused to the endogenous *sur-5* gene (*sur-5::gfp*, [Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). This strain resulted in the expression of a nuclear-localized SUR-5::GFP fusion protein, enabling simultaneous visualization of every somatic nucleus using confocal microscopy (Figure [4A](#F4){ref-type="fig"}). Expression of *gfp*-dsRNA in neurons resulted in silencing throughout the length of the animal that was entirely dependent on SID-1, consistent with silencing by neuronal dsRNA (Figure [4B](#F4){ref-type="fig"} and Figure [4C](#F4){ref-type="fig"}) and was not subject to silencing upon *eri-1* loss by target-derived dsRNA ([Supplementary Figure S7A-C](#sup1){ref-type="supplementary-material"}) as is expected for a single-copy target ([@B35]). Silencing was easily detected in intestinal cells, hypodermal cells, body-wall muscle cells, and the excretory canal cell (Figure [4B](#F4){ref-type="fig"} and [Supplementary Figure S8A](#sup1){ref-type="supplementary-material"}). Silencing was not detectable in some cells in the head, the vulval and uterine regions, and occasionally in the tail region ([Supplementary Figure S8A](#sup1){ref-type="supplementary-material"}). Interestingly, even neighboring, lineal sister cells sometimes showed very different extents of silencing (e.g. intestinal cells near the tail in [Supplementary Figure S8A](#sup1){ref-type="supplementary-material"}, *top row*). Nevertheless, the overall silencing observed was much more than that observed when the same source of dsRNA was used to silence a multi-copy *sur-5::gfp* transgene (1.0±0.4 visible intestinal nuclei for single-copy *sur-5::gfp* ([Supplementary Figure S7C](#sup1){ref-type="supplementary-material"}) versus 24.0±1.9 visible intestinal nuclei for multi-copy *sur-5::gfp* (Figure [1A](#F1){ref-type="fig"}), *P*-value \<10^−21^ and errors indicate 95% CI). A simple explanation for this difference could be that silencing higher numbers of target transcripts requires higher amounts of dsRNA (see Discussion for additional possibilities). Thus, the single-copy *sur-5::gfp* gene is a sensitive target for evaluating the use of EGO-1 for silencing by neuronal dsRNA in somatic cells throughout the animal.

Silencing of single-copy *sur-5::gfp* by neuronal dsRNA was detectable in *rrf-1(-)* animals (Figure [4D](#F4){ref-type="fig"}), but the extent of silencing and the locations of cells that showed silencing varied dramatically from animal to animal ([Supplementary Figure S7D](#sup1){ref-type="supplementary-material"}). To obtain a high-resolution view of silencing, we quantified silencing in multiple tissues by counting the number of nuclei that show fluorescence ([Supplementary Movie S1](#sup1){ref-type="supplementary-material"}). For quantifying silencing in hypodermal and body-wall muscle cells, we divided the body into three regions ([Supplementary Figure S8B](#sup1){ref-type="supplementary-material"}, *Left*): head (anterior to the posterior bulb of the pharynx), anterior body (anterior to the vulva), and posterior body (posterior to the vulva). In the head and anterior body, the average numbers of detectable nuclei in *rrf-1(-)* animals were not very different from the average numbers detectable in *sid-1(-)* animals ([Supplementary Figure S8B](#sup1){ref-type="supplementary-material"}, *Right*). The posterior body, however, showed marginal silencing of hypodermal and/or body-wall muscle cells in *rrf-1(-)* animals (50.0±7.6 nuclei versus 58.7±4.6 nuclei in *sid-1(-), P*-value = 0.08 and errors indicate 95%CI), suggestive of some use of EGO-1 for silencing. The intestine, however, showed obvious silencing in the absence of RRF-1. This silencing was associated with a reduction in mRNA levels (Figure [4E](#F4){ref-type="fig"} and [F](#F4){ref-type="fig"}) and required MUT-16 and EGO-1 ([Supplementary Figure S7E](#sup1){ref-type="supplementary-material"}). Notably, loss of EGO-1 alone does not result in a detectable defect in silencing by neuronal dsRNA ([Supplementary Figure S7F](#sup1){ref-type="supplementary-material"}), suggesting that EGO-1 is not required for silencing in any intestinal cell but rather can compensate for loss of RRF-1.

Because each of the 20 intestinal cells has an invariable lineal origin and position after morphogenesis (Figure [4G](#F4){ref-type="fig"}, ([@B52])), we were able to examine whether silencing occurs in any discernible pattern correlated with lineage or position. Each tested worm had a different complement of cells with respect to RdRP use for silencing (Figure [4G](#F4){ref-type="fig"} and [Supplementary Figure S7D](#sup1){ref-type="supplementary-material"}) such that no cell relied on only RRF-1 in every animal and no cell could use EGO-1 in every animal (Figure [4G](#F4){ref-type="fig"}).

Together, these results show that neuronal dsRNA can cause robust silencing, but the particular cells that require RRF-1 for such silencing vary from animal to animal.

DISCUSSION {#SEC4}
==========

We examined RNA interference in the somatic cells of *C. elegans* and found that the source of extracellular dsRNA, the context of target sequences, and the identity of the tested cell can all dictate whether the RNA-dependent RNA polymerase RRF-1 is required for silencing. We discovered that silencing by neuronal dsRNA can be extensive and, when examined at single-cell resolution, different sets of cells rely on only RRF-1 or could also use EGO-1 in the absence of RRF-1 for silencing in each animal.

Silencing by neuronal dsRNA {#SEC4-1}
---------------------------

Expression of dsRNA in all neuronal cells resulted in SID-1-dependent silencing in a variety of cell types throughout the animal (hypodermal cells, body-wall muscle cells, seam cells, intestinal cells, and excretory canal cell; Figure [4](#F4){ref-type="fig"} and [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}), suggesting that dsRNA molecules exported from neurons are widely available. Subsequent import depends on the levels of SID-1 in importing cells because cells that overexpress SID-1 can act as sinks for dsRNA and presumably reduce entry of dsRNA into other cells ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"} in ([@B8],[@B73])). The observed widespread silencing (Figure [4](#F4){ref-type="fig"}) therefore suggests that no single tissue acts as a sink and that sufficient dsRNA is exported from neurons to reach cells throughout the animal.

Yet, silencing by neuronal dsRNA is not always detectable in all cells, which could reflect either inefficient import of dsRNA or inefficient silencing. For example, most intestinal cells were not silenced when neuronal dsRNA was used to silence a multi-copy *sur-5::gfp* transgene (Figure [1A](#F1){ref-type="fig"}). However, silencing of this multi-copy target was greatly enhanced upon loss of *eri-1* (Figure [1A](#F1){ref-type="fig"}), which releases shared factors used for endogenous RNAi-related processes ([@B74]). Therefore, this case of limited silencing by neuronal dsRNA likely reflects limited availability of such RNAi factors (e.g. RDE-4, DCR-1, etc.) and not poor access to dsRNA or poor import of dsRNA. Similarly, the lack of silencing of single-copy *sur-5::gfp* in the cells of some tissues (pharynx, vulva, and uterus, [Supplementary Figure S8A](#sup1){ref-type="supplementary-material"}) could reflect inefficient silencing that could potentially be enhanced by providing limiting factors.

Genes required for the biogenesis and/or export of dsRNA from cells are currently unknown. Genetic screens that could have isolated mutations in such genes targeted fluorescent proteins expressed from repetitive transgenes for silencing by extracellular dsRNA (([@B13],[@B61]), and this study). Because repetitive transgenes are themselves sources of dsRNA that can result in self-silencing (e.g. ([@B8])) or in inhibition of silencing by extracellular dsRNA ([@B18]), the mechanism(s) of silencing disrupted in mutants from these screens are unclear. Nevertheless, these screens isolated genes required for import of dsRNA (*sid-1* ([@B13]), *sid-2* ([@B75]), *sid-3* ([@B76]), *sid-4* ([@B77]), *sid-5* ([@B78])), or for silencing within target cells (*rde-10* ([@B61],[@B62]), *rde-11* ([@B61],[@B62])). We have constructed a screenable worm that could be used to isolate genes required for the biogenesis and/or export of dsRNA without confounding effects from repetitive transgenes expressed in target cells (Figure [4](#F4){ref-type="fig"}). A repetitive source of dsRNA from neurons, on the other hand, could be necessary for robust silencing of *sur-5::gfp* (Figure [4](#F4){ref-type="fig"}), although it does not guarantee robust silencing as evidenced by the weak silencing of *bli-1* (Supplemental Figure 6A). Whether a single copy source of dsRNA can result in the export of dsRNA from neurons and efficient silencing of any target gene in distant cells is unclear.

Cellular origins of small RNAs {#SEC4-2}
------------------------------

A wide range of endogenous small RNAs (miRNAs, siRNAs, piRNAs etc.) is being analyzed by sequencing RNA from whole worms. Where any particular small RNA is made and where it acts are both obscured when worms are homogenized for extracting RNA. Base-paired RNAs such as long dsRNA ([@B79]), precursors of miRNAs ([@B22],[@B23]) or precursors of 26G RNAs ([@B68],[@B69]) could be transported through SID-1 such that they are made in one cell and cause effects in other cells. However, tests for such non-autonomous effects of the *lin-4* miRNA suggest cell-autonomous action of this miRNA ([@B80]). Examination of some of the numerous anti-sense RNAs called 22G RNAs suggested that they are made by RRF-1 in somatic cells and both RRF-1 and EGO-1 in the germline ([@B81]). Our results suggest the possibility that some 22G RNAs could be made in the intestine in the absence of RRF-1 potentially using EGO-1 in the intestine or through indirect effects of EGO-1 function in the germline. Resolving the origin and the site of action of such an endogenous small RNA requires controlled experiments that consider both non-cell autonomy of the RNA and functional mosaicism of its biogenesis.

Functional mosaicism of RNAi in an animal {#SEC4-3}
-----------------------------------------

The identities of the intestinal cells that strictly require RRF-1 for silencing by neuronal dsRNA varied from animal to animal (Figure [4G](#F4){ref-type="fig"} and [Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). This variation observed in *rrf-1(-)* animals could be because of unequal and random availability of compensatory EGO-1 despite equal availability of neuronal dsRNA or because of unequal and random availability of neuronal dsRNA despite equal availability of compensatory EGO-1 ([Supplementary Figure S9](#sup1){ref-type="supplementary-material"}). Such functional mosaicism is masked in wild-type animals, where the amplification of silencing signals by RRF-1 results in uniform silencing. Thus, RRF-1 promotes silencing by extracellular dsRNA to ensure uniform silencing - a role that is reminiscent of the role for ERI-1 in opposing silencing by transgene-derived dsRNA to ensure uniform expression ([@B35]).

RNAi is an antiviral mechanism in many organisms (see ([@B82]) for a recent evolutionary perspective) and wild strains of *C. elegans* that are defective in RNAi can harbor viruses ([@B83]). Viral infection of *C. elegans* in the lab results in proliferation of the virus in some but not all intestinal cells ([@B84]). It would be interesting to determine whether mosaicism of specific components of the RNAi machinery underlies patterns of viral infection observed in the intestine of *Caenorhabditis* nematodes ([@B83],[@B84]). We speculate that functional mosaicism and its control could be common in multicellular organisms because of the need to balance diversification of cell types with preservation of fundamental functions in all cells.

Functional mosaicism could enable escape from targeted therapies {#SEC4-4}
----------------------------------------------------------------

Current examples of escape from therapeutic interventions could reflect unanticipated functional mosaicism -- especially when such escape occurs in the absence of genetic mutations or overt differences. For example, bacterial cells can persist after treatments with antibiotics and the presence of such persister cells does not reflect genetic heterogeneity ([@B85]), but rather could reflect differences in underlying mechanisms among similar cells. Furthermore, while the genetic variation in cancers is well appreciated as a cause of resistance and relapse ([@B86]), the possible role of functional mosaicism as an additional contributor merits exploration.

Functional mosaicism could allow developmental systems to drift over evolutionary time {#SEC4-5}
--------------------------------------------------------------------------------------

Analyses of variation in intact animals where organismal regulatory mechanisms are preserved, as described here using *C. elegans*, are an effective complement to analyses in single cells, which have begun to reveal heterogeneity in many processes (e.g. in gene expression ([@B87]), in membrane trafficking ([@B88]), and in subcellular organization ([@B89])). This variation can be modified by the presence of maternal/zygotic factors (e.g. exonuclease ERI-1 ([@B35])) or secreted factors (e.g. extracellular dsRNA, this study) that can act during development. Such modifiers of variation could allow diversification of underlying mechanisms in response to selection for the same function. As a result, functional mosaicism could persist without differences in phenotype. This hypothetical sequence of events supports the plausibility of mosaicism in a process existing in the ancestors of organisms with divergent developmental systems that nevertheless perform the same function ([@B90]). Consistently, evolutionary comparisons in nematodes and in arthropods suggest that transposons are silenced using a plurality of mechanisms that could have diverged from ancestors with multiple mechanisms ([@B67],[@B91]). For example, efficient silencing can occur in the absence of RRF-1-like RdRPs (using RRF-3-like processive RdRPs ([@B67])) or without any RdRPs ([@B67],[@B91]). Evaluation of this hypothesis for any process requires analyses in closely related species at single-cell resolution.
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